InsiderTrades

Form 4 for CVS CVS Health

Accepted 2022-03-31 00:00:00 ET · period of report 2022-03-30 · accession 0001127602-22-010749 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-31 2022-03-30 CVS Shah Prem S EVP, Co-Pres of Retail M - OptEx $102.26 +5,346 64.4K +9% +$546.7K
D 2022-03-31 2022-03-30 CVS Shah Prem S EVP, Co-Pres of Retail S - Sale+OE $104.70 -5,346 59.1K -8% -$559.7K
D 2022-03-31 2022-03-30 CVS Shah Prem S EVP, Co-Pres of Retail M - OptEx $0.00 -5,346 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-30 M A 5,346 $102.26 64,417.24 D — —
2 Common Common Stock 2022-03-30 S D 5,346 $104.70 59,071.24 D — —
3 Derivative Stock Option 2022-03-30 M D 5,346 $0.00 0 D $102.26 · 2016-04-01 to 2022-04-01 5,346 Common Stock (F10) Option becomes exercisable in four equal installments commencing 04/01/2016.